Fundacion Dexeus
dexeus.comTotal trials
35
Active
5
Phase 3
1
Total enrollment
8,649
Read this sponsor's pipeline like an analyst.
Generate a written report: strategic focus, priority programs, pipeline shape, recent terminations and momentum, and the trials worth watching in the next 12 months.
~15-30 sec · cached for 24h
Pipeline matrix
Showing 3 of 3 active programs · click any cell for trials
| Intervention | Early Phase 1 | Phase 1 | Phase 2 | Phase 3 | Phase 4 | N/A | Total |
|---|---|---|---|---|---|---|---|
| Subcutaneous Triptorelin | — | — | — | — | — | 1 | |
| Intranasal nafarelin | — | — | — | — | — | 1 | |
| Semaglutide | — | — | — | — | — | 1 |
Next readouts
- 2026-01-15
- 2027-02
Top conditions
- Infertility18
- Oocyte Donation3
- Polycystic Ovary Syndrome2
- Fertility Disorders2
- Infertility, Female2
- Preimplantation Genetic Screening2
- Progesterone2
- Embryo Transfer2
Frequently asked questions about Fundacion Dexeus
- How many clinical trials does Fundacion Dexeus have on ClinicalTrials.gov?
- Fundacion Dexeus is listed as the lead sponsor on 35 clinical trials in ClinicalTrials.gov, 5 of which are currently active (recruiting, enrolling, or ongoing).
- How many of Fundacion Dexeus's trials are in Phase 3?
- 1 of Fundacion Dexeus's trials are in Phase 3, spread across 3 active drug programs.
- What therapeutic areas does Fundacion Dexeus focus on?
- Fundacion Dexeus's most-studied conditions on ClinicalTrials.gov are Infertility, Oocyte Donation, Polycystic Ovary Syndrome, Fertility Disorders, Infertility, Female.
- When are Fundacion Dexeus's next clinical trial readouts?
- Fundacion Dexeus has 2 upcoming primary-completion readouts tracked here; the soonest is “Intranasal Nafarelin For Triggering Oocyte Maturation”, expected around 2026-01-15.